Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A1 | P18405 | 5/20 | 0.65 |
| ▸ | SRD5A2 | P31213 | 5/20 | 0.65 |
| ▸ | CNR1 | P21554 | 7/20 | 0.50 |
| ▸ | CNR2 | P34972 | 10/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9334109 | 1.00 | SRD5A1 (0.65) | SRD5A1SRD5A2CNR1CNR2POLB | |
| SCHEMBL9337492 | 0.99 | SRD5A1 (0.65) | SRD5A1SRD5A2CNR1CNR2POLB | |
| SCHEMBL9337367 | 0.97 | SRD5A1 (0.66) | SRD5A1SRD5A2CNR1CNR2POLB | |
| SCHEMBL9335702 | 0.95 | SRD5A1 (0.67) | SRD5A1SRD5A2CNR1CNR2POLB | |
| SCHEMBL9441145 | 0.93 | SRD5A1 (0.67) | SRD5A1SRD5A2CNR1CNR2POLB | |
| SCHEMBL9337524 | 0.92 | SRD5A1 (0.77) | SRD5A1SRD5A2CNR1CNR2 | |
| SCHEMBL9334526 | 0.92 | SRD5A1 (0.77) | SRD5A1SRD5A2CNR1CNR2 | |
| SCHEMBL8793566 | 0.92 | SRD5A1 (0.69) | SRD5A1SRD5A2CNR1CNR2POLB | |
| SCHEMBL9545091 | 0.91 | SRD5A1 (0.65) | SRD5A1SRD5A2CNR1CNR2POLB | |
| SCHEMBL9543375 | 0.91 | SRD5A1 (0.65) | SRD5A1SRD5A2CNR1CNR2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5312829-A | Testosterone 5alpha-reductase inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-05-17 | — | — | US | disclosed |
| US-5212320-A | Enzyme inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-05-18 | — | — | US | disclosed |